Anticorps Monoclonal anti-TGFBI / BIGH3

TGFBI / BIGH3 Monoclonal Antibody for Single Cell (Intra)

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain

Applications

Single Cell (Intra)

Conjugaison

5CFLX Fluorescent Dye

CloneNo.

3E11D11

N° de cat : G60007-1-5C

Synonymes

Beta ig h3, BIGH3, CDB1, CDG2, CDGG1, CSD, CSD1, CSD2, CSD3, EBMD, Kerato epithelin, LCD1, RGD CAP, TGFBI, TGFBI / BIGH3



Applications testées

Résultats positifs en Single Cell (Intra)10x Genomics Gene Expression Flex with Feature Barcodes and Multiplexing product.

Dilution recommandée

ApplicationDilution
SINGLE CELL (INTRA)SINGLE CELL (INTRA) : <0.5ug/test
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

G60007-1-5C cible TGFBI / BIGH3 dans les applications de Single Cell (Intra) et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Mouse / IgG2a
Clonalité Monoclonal
Type Anticorps
Immunogène TGFBI / BIGH3 Protéine recombinante Ag0241
Nom complet transforming growth factor, beta-induced, 68kDa
Masse moléculaire calculée 683 aa, 75 kDa
Numéro d’acquisition GenBankBC000097
Symbole du gène TGFBI
Identification du gène (NCBI) 7045
Conjugaison 5CFLX Fluorescent Dye
Forme Liquide
Méthode de purification
Tampon de stockage PBS with 1mM EDTA and 0.09% sodium azide
Conditions de stockage2-8°C Stable for one year after shipment. 20ul contiennent 0,1% de BSA.

Informations générales

TGFBI, also named as BIGH3, Kerato-epithelin and RGD-CAP, binds to type I, II, and IV collagens. TGFBI is an adhesion protein which may play an important role in cell-collagen interactions. In cartilage, it may be involved in endochondral bone formation. TGFBI is an extracellular matrix adaptor protein, it has been reported to be differentially expressed in transformed tissues. TGFBI is a predictive factor of the response to chemotherapy, and suggest the use of TGFBI-derived peptides as possible therapeutic adjuvants for the enhancement of responses to chemotherapy.(PMID:20509890) Defects in TGFBI are the cause of epithelial basement membrane corneal dystrophy (EBMD). Defects in TGFBI are the cause of corneal dystrophy Groenouw type 1 (CDGG1). Defects in TGFBI are the cause of corneal dystrophy lattice type 1 (CDL1). Defects in TGFBI are a cause of corneal dystrophy Thiel-Behnke type (CDTB). Defects in TGFBI are the cause of Reis-Buecklers corneal dystrophy (CDRB). Defects in TGFBI are the cause of lattice corneal dystrophy type 3A (CDL3A). Defects in TGFBI are the cause of Avellino corneal dystrophy (ACD).

{{ptg:RelatedPrimaryAntibodies}}